LivaNova PLC (LIVN) stock analysis
LIVN · LivaNova PLC
Latest recorded price: USD 92.44
Model-estimated fair value: USD 12.77. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $92.44, LIVN trades 623.7% above the model's base-case value of $12.77. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $10.98 in the conservative case and $14.99 in the optimistic case, with a valuation confidence score of 45/100. Fiscal 2025 figures: revenue growth 10.8%, free cash flow margin 12.5%, ROIC 16.9%. The model does not flag any risk signals for this company.